CytomX Therapeutics Inc (CTMX) stock news · rev $76.2M
CytomX Therapeutics Inc (CTMX) is a biotechnology company listed on US.
This CTMX news page leads with what CytomX Therapeutics Inc filed — not a scraped headline mill.
No cached 8-K sentence for CTMX yet. We will not pad this page with generic market recap.
Latest reported CTMX revenue for 2025-12-31 was $76.2M. Net income was -$17.4M. Revenue was down 44.8% from 2024-12-31 to 2025-12-31. CTMX currently screens at market cap $653.1M.
EDGAR remains the official archive. Lician caches the exhibit so you can read what changed without a wire story.
Not investment advice. For the model open the CTMX stock page; for the tape open the quote page.
CTMX stock news FAQ
What are CTMX's latest revenue and net income?
Latest cached CytomX Therapeutics Inc (CTMX) revenue for Dec 31, 2025 was $76.2M. Net income was -$17.4M. Statements: https://lician.com/financials/ctmx
How did CTMX revenue change from the prior cached period?
Cached CytomX Therapeutics Inc (CTMX) revenue was down 44.8% from $138.1M (Dec 31, 2024) to $76.2M (Dec 31, 2025). Statements: https://lician.com/financials/ctmx
What is CTMX's market cap?
CytomX Therapeutics Inc (CTMX) market cap is $653.1M on the latest cached fundamentals snapshot.
What kind of company is CTMX?
CytomX Therapeutics Inc (CTMX) is a biotechnology company listed on US.
Where is CTMX stock news listed?
Cached stock news for CytomX Therapeutics Inc (CTMX) is listed at https://lician.com/news/ctmx. Filings: https://lician.com/sec/ctmx
Not investment advice.